A Study of Olaratumab in Japanese Participants With Advanced Cancer

Status Completed

Clinical Trial Summary

This study consists of 2 parts (Part A and Part B). The main purpose of Part A is to evaluate safety and side effects of olaratumab in combination with doxorubicin in Japanese participants with a group of rare cancers (advanced solid tumors, especially advanced soft tissue sarcoma [STS].) The main purpose of Part B is to evaluate how much olaratumab gets into the blood stream of Japanese participants with advanced solid tumors and how long it takes the body to get rid of it.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Neoplasm

Clinical Trial Details

NCT number	NCT02377752
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 1
Start date	March 23, 2015
Completion date	January 14, 2020

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01441115` - ECI301 and Radiation for Advanced or Metastatic Cancer	Phase 1
Completed	`NCT00199836` - A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.	Phase 1
Completed	`NCT01672944` - Evaluating Biobanking Educational Tools	N/A
Not yet recruiting	`NCT02226289` - Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment	Phase 2
Completed	`NCT02747342` - A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer	Phase 1
Completed	`NCT02759640` - A Phase I Trial of HS-10241 in Solid Tumors	Phase 1
Completed	`NCT02746185` - Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban	Phase 3
Completed	`NCT02536586` - A Study of LY3023414 in Japanese Participants With Advanced Cancer	Phase 1
Completed	`NCT02309164` - The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).	N/A
Completed	`NCT02394821` - Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide	Phase 3
Completed	`NCT01457196` - Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions	N/A
Completed	`NCT00143533` - Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors	Phase 1
Recruiting	`NCT05450562` - Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors	Phase 1/Phase 2
Completed	`NCT00001835` - Oxaliplatin in Cancer Patients With Impaired Kidney Function	Phase 1
Completed	`NCT00001341` - A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease	Phase 1
Completed	`NCT01425008` - Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma	Phase 1
Recruiting	`NCT05101798` - The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial	Phase 2
Completed	`NCT01920061` - A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)	Phase 1
Terminated	`NCT03251924` - A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT02851706` - Natural History of and Specimen Banking for People With Tumors of the Central Nervous System